Where does Glaceum Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Glaceum Inc. ranks #40,438 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Glaceum Inc. hold?

Glaceum Inc. holds 6 US utility patents granted between 2017 and 2022, spanning 7 technology areas.

What is Glaceum Inc.'s Innovation Score?

Glaceum Inc. has an Innovation Score of 32.7 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Glaceum Inc. focus on?

Glaceum Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Glaceum Inc.'s patent grant rate increasing or decreasing?

Glaceum Inc.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Glaceum Inc.'s patents?

Glaceum Inc.'s patents average 11.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Glaceum Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Glaceum Inc.

USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glaceum ranks #40,438 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.

#40,438
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.7/100): 11.0
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40438 · Foreign Corporation #40,438 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #40,438/49,997
PHOTO-FINISH Gimac DI Maccagnan…
CPC-NARROW A61P · 7 areas
INNOV-THIN 32.7/100
CLAIMS-PAR 11.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gimac DI Maccagnan Giorgio (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glaceum’s 32.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (20%) Velocity 10.0 pts (31%) Breadth 9.4 pts (29%) Claim depth 6.6 pts (20%)

Qualcomm Incorporated · highest

85
Glaceum · this assignee

33
3D Lighting… · lowest

7

What this shows Glaceum's Innovation Score is 32.7/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Glaceum?

Each dot is one of Glaceum’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glaceum’s own 11.0 claims/patent is at or below the 12.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Glaceum vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glaceum's grants concentrate

Glaceum Inc. is a focused PatentsView assignee: 7 CPC subclasses with 83.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2017. By volume, Glaceum sits between Gimac DI Maccagnan Giorgio and Glycofi, Inc..

Glaceum's three-year grant acceleration

Glaceum Inc. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gimac DI Maccagna…

6
Givi S P A

6
Gjosa

6
GKN Aerospace Ser…

6
Global Material I…

6
Global Media Indu…

6
Glory Metal Produ…

6
Glycofi

6
Glaceum ◀

6

What this shows Glaceum holds 6 patents at rank #40,394, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Glaceum

By rank, the assignees closest to #40,394 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Glaceum's primary technology class.

Glaceum's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Glaceum Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	16.7%
2020	1	16.7%
2021	1	16.7%
2022	3	50.0%

Which technologies does Glaceum Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C07D - Heterocyclic Compounds 5

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Glaceum Inc.'s patent record in context - here's where to go next.

Glaceum Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 83.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #40,438 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Glaceum Inc. against Gimac DI Maccagnan Giorgio, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.